FFCP PHASE1:Hg19::chr15:66446191..66446202,-: Difference between revisions
From FANTOM5_SSTAR
m (moved FFCP PHASE1 hg19::chr15:66446191..66446202,- to FFCP PHASE1:Hg19::chr15:66446191..66446202,-: NSchange) |
No edit summary |
||
(9 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
| | |DHSsupport=supported | ||
| | |DPIdataset=robust | ||
|EntrezGene=NA | |EntrezGene=NA | ||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |HGNC=NA | ||
|TSSclassifier=strong | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |||
|cluster_id=chr15:66446191..66446202,- | |||
|coexpression_cluster_id=C138 | |||
|description=CAGE_peak_at_chr15:66446191..66446202,- | |||
|id=chr15:66446191..66446202,- | |||
|ontology_enrichment_celltype=CL:0000819!1.07e-23!1;CL:0000945!3.42e-15!24;CL:0000826!3.42e-15!24;CL:0000785!1.48e-12!2;CL:0000955!1.48e-12!2;CL:0000818!1.48e-12!2;CL:0000954!1.48e-12!2;CL:0000816!1.48e-12!2;CL:0002535!2.07e-12!2;CL:0000242!2.90e-12!2;CL:0000817!8.31e-09!3;CL:0000838!3.28e-07!52;CL:0000542!4.43e-07!53;CL:0000051!4.43e-07!53 | |||
|ontology_enrichment_celltype_v019=CL:0000785;9.37e-99;1!CL:0000819;9.37e-99;1!CL:0000945;1.03e-17;24!CL:0000542;3.98e-11;53!CL:0000236;5.28e-09;13 | |||
|ontology_enrichment_celltype_v019_2=CL:0000819,9.37e-99,1;CL:0000785,2.74e-50,2;CL:0000955,2.74e-50,2;CL:0000818,2.74e-50,2;CL:0000954,2.74e-50,2;CL:0000816,2.74e-50,2;CL:0000817,4.27e-34,3;CL:0000945,1.03e-17,24;CL:0000826,1.03e-17,24;CL:0000838,6.99e-09,52;CL:0000542,9.74e-09,53;CL:0000051,9.74e-09,53;CL:0000236,1.86e-08,14 | |||
|ontology_enrichment_development_v019=CL:0000954;2.74e-50;2!CL:0000051;3.98e-11;53 | |||
|ontology_enrichment_disease=DOID:0060058!1.05e-35!10;DOID:0060073!1.07e-23!1;DOID:8675!1.07e-23!1;DOID:4362!1.24e-18!5;DOID:0050686!1.04e-07!137;DOID:2531!2.40e-07!51;DOID:0060083!2.40e-07!51;DOID:5409!8.61e-07!4 | |||
|ontology_enrichment_disease_v019=DOID:0060073;9.37e-99;1!DOID:8675;9.37e-99;1!DOID:0060058;2.00e-40;10!DOID:2531;8.54e-09;51!DOID:0060083;8.54e-09;51 | |||
|ontology_enrichment_disease_v019_2=DOID:0060073,9.37e-99,1;DOID:8675,9.37e-99,1;DOID:0060058,2.00e-40,10;DOID:2531,4.95e-09,51;DOID:0060083,4.95e-09,51 | |||
|ontology_enrichment_uberon=UBERON:0002372!6.40e-23!1;UBERON:0001961!6.40e-23!1;UBERON:0001744!6.40e-23!1;UBERON:0001735!6.40e-23!1;UBERON:0000002!1.05e-15!6;UBERON:0001560!1.05e-15!6;UBERON:0006955!2.07e-12!2;UBERON:0004801!2.07e-12!2 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.16200800870452,0.142169232487422,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.251932747854276,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.9893034411739,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.974340787047167,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.144921028610825,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.233939463462106,0,0,0,0,0.150962843566674,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.134704106029175,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.16200800870452,0.142169232487422,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.251932747854276,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.9893034411739,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.974340787047167,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.144921028610825,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.233939463462106,0,0,0,0,0.150962843566674,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.134704106029175,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr15:66446191..66446202,- | |||
}} | }} |
Latest revision as of 03:32, 25 July 2015
Short description: | p@chr15:66446191..66446202, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr15:66446191..66446202, - |
Coexpression cluster: | C138_diffuse_Burkitt_lymphangiectasia_lymphoma_acute_CD19_pineal |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
B-1 B cell | 9.37e-99 | 1 |
mature B cell | 2.74e-50 | 2 |
pre-B-II cell | 2.74e-50 | 2 |
transitional stage B cell | 2.74e-50 | 2 |
small pre-B-II cell | 2.74e-50 | 2 |
immature B cell | 2.74e-50 | 2 |
precursor B cell | 4.27e-34 | 3 |
lymphocyte of B lineage | 1.03e-17 | 24 |
pro-B cell | 1.03e-17 | 24 |
lymphoid lineage restricted progenitor cell | 6.99e-09 | 52 |
lymphocyte | 9.74e-09 | 53 |
common lymphoid progenitor | 9.74e-09 | 53 |
B cell | 1.86e-08 | 14 |
Ontology term | p-value | n |
---|---|---|
lymphatic system cancer | 9.37e-99 | 1 |
lymphosarcoma | 9.37e-99 | 1 |
lymphoma | 2.00e-40 | 10 |
hematologic cancer | 4.95e-09 | 51 |
immune system cancer | 4.95e-09 | 51 |